BioCanada

Found 21,059 articles

• Gilead Receives Approval in Canada for YESCARTA™ (Axicabtagene Ciloleucel) CAR T Therapy for Adults With Relapsed or Refractory Large B-cell Lymphoma After Two or More Lines of Systemic Therapy

  2/19/2019

  YESCARTA is a chimeric antigen receptor T (CAR T) cell therapy that is custom-made for each patient from his or her own T cells.

• Fusion Pharma Announces First Patient Dosing in a Phase 1 Clinical Trial of [225Ac]-FPI-1434 Injection in Patients with Advanced Solid Tumors

  2/19/2019

  Fusion Pharmaceuticals, a biopharmaceutical company focused on radiotherapeutics, announced that the first patient was dosed in a Phase 1, first-in-human clinical trial of lead product candidate [225Ac]-FPI-1434 in patients with advanced solid tumors.

• Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies

  2/19/2019

  If Approved, EM-100 Will Be the First OTC Preservative-Free Formulation of Its Kind

• Agrios Global Holdings Ltd. Appoints Former Organa Brands Executive Robert Lanterman VP Product Development

  2/19/2019

  Former Director of Sales at Organa Brands, now Slang Worldwide

• Beleave Announces Board and Management Refresh

  2/19/2019

  Announce a refresh of its Board of Directors with the appointment of three new Independent Directors and one Inside Director to enhance the Company's focus on governance, and emerging and capital markets.

• Imperial Tobacco Canada supports action to stop youth vaping

  2/19/2019

  Teachers and parents across the country see it daily: teens are getting access to vapour products and are vaping.

• Tilray® Increases Cannabis Supply with Acquisition of Natura Naturals Holdings

  2/19/2019

  Closing transaction of acquisition boosts Company’s capacity to supply cannabis products across Canada

• Veterinary Practices Keep Pulse on Business Via New Interactive Daily Dashboards

  2/19/2019

  VetSuccess launches innovative business intelligence product.

• FSD Pharma Receives Standard Processing License

  2/19/2019

  FSD Pharma Inc. announced that its wholly-owned subsidiary, FV Pharma Inc., a licensed cannabis producer under the Cannabis Act, has received its Standard Processing License.

• National Social Art Forum - Serving youth homelessness

  2/18/2019

  On February 22 and 23, 2019, the Musée national des beaux-arts du Québec will host the National Social Art Forum.

• Government of Canada Announces Funding to Help Prevent Teen Dating Violence

  2/18/2019

  Projects will provide students with skills and resources to recognize unhealthy relationships

• Information Update - Health Canada recommends that children and youth not use cough and cold products that contain opioids

  2/18/2019

  The Government of Canada is committed to better informing Canadians about the risks of health products that contain opioids.

• 

  WHO Plans to Develop Oversight Standards for Gene Editing Following Chinese Researcher’s Experiment

  2/15/2019

  Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.

• Bausch Health Provides Update For DUOBRII Filing

  2/15/2019

  Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration will be unable to meet today's Prescription Drug User Fee Act date for the New Drug Application for DUOBRII™ Lotion, 0.01%/0.045%, for the topical treatment of plaque psoriasis in adults.

• Arcane Provides Digital Leadership as Orangetheory Fitness Breaks Into Canadian Market

  2/15/2019

  Since launching its first Canadian studio in 2012, Orangetheory Fitness has experienced rapid expansion, now with 87 locations in Canada – with many more on the way.

• /R E P E A T -- Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M/

  2/15/2019

  Canopy Growth Corporation released its consolidated financial results for the third quarter fiscal 2019 ended December 31, 2018.

• /R E P E A T -- Notice to the media - The Governments of Canada and Prince Edward Island will announce new measures to increase access to treatment for substance use disorder/

  2/15/2019

  The Honourable Lawrence MacAulay, federal Minister of Agriculture and Agri-Food, and the Honorable Jordan Brown, Minister of Education, Early Learning and Culture and Minister of Justice and Public Safety for Prince Edward Island will announce new measures to increase access to treatment.

• Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M

  2/15/2019

  Cannabis shipments totaled 10,102 kilograms and kilogram equivalents.

• Advisory - Unauthorized prescription product Kobayashi Aibon/Eyebon Eyewash seized from Tokyo Beauty & Health Care in Richmond, B.C., may pose serious health risks

  2/15/2019

  Health Canada is advising consumers that the unauthorized product "Kobayashi Aibon/Eyebon Eyewash" is labelled to contain a prescription drug (aminocaproic acid) and may pose serious health risks.

• The governments of Canada and Prince Edward Island increase access to treatment options for people with substance use disorders

  2/15/2019

  The opioid crisis is devastating individuals, families and communities across the country. Without increased access to effective, evidence-based treatment options, people with substance use disorders will continue to be at risk for overdose.